Sweeteners--an overview. Part. 1.
D001218:Aspartame / Q000494:pharmacology; D002599:Chalcone / Q000031:analogs & derivatives / Q000494:pharmacology; D047188:Chalcones; D003494:Cyclamates / Q000009:adverse effects; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D019695:Glycyrrhizic Acid; D006569:Hesperidin / Q000031:analogs & derivatives / Q000494:pharmacology; D007576:Jaw, Edentulous, Partially / Q000628:therapy; D007880:Legislation, Drug; D010078:Oxazines / Q000494:pharmacology; D012439:Saccharin / Q000009:adverse effects; D013402:Sugar Alcohols / Q000494:pharmacology; D013843:Thiazines / Q000494:pharmacology; D014993:Xylitol / Q000494:pharmacology
D047188:Chalcones; D003494:Cyclamates; D010078:Oxazines; D013402:Sugar Alcohols; D013843:Thiazines; C013613:neohesperidin dihydrochalcone; D002599:Chalcone; D019695:Glycyrrhizic Acid; D006569:Hesperidin; D012439:Saccharin; C006362:acetosulfame; D006034:Glycyrrhetinic Acid; D014993:Xylitol; D001218:Aspartame